Oct. 22 - Scientists have developed a new gene-editing technology that could potentially correct up to 89% of genetic defects, including those that cause diseases like sickle cell anemia. The new technique is called "prime editing," and was developed by researchers from the Broad Institute of MIT and Harvard, who published their findings in the journal Nature.
Oct. 17 - Scientists have uncovered a novel antibiotic-free approach that could help prevent and treat one of the most widespread bacterial pathogens, using nanocapsules made of natural ingredients.
Oct. 16 - A new method can deliver DNA into immune cells with minimal stress on these cells, which could solve a problem with a current immunotherapy technique, researchers report.
Oct. 16 - To successfully engineer cell or tissue implants, bioengineers must facilitate their metabolic requirements through vascular regeneration. However, it is challenging to develop a broad strategy for stable and functional vascularization. In a recent report in Nature Communications, Wei Song and colleagues describe highly organized, biomimetic and resilient microvascular meshes.
Oct. 17 - Lung transplantation can be a life-extending option, but severe postoperative complications—including reduced lung function caused by organ rejection—often affect a recipients’ quality of life and limit long-term survival. Now, as part of an effort to improve long-term outcomes, a national team led by a researcher at Penn Medicine has launched a study to better understand clinical and biological processes that occur after transplant and lead to the development of these complications.